logo
ResearchBunny Logo
Combined KRAS G12C and SOS1 inhibition enhances and extends the anti-tumor response in KRAS G12C -driven cancers by addressing intrinsic and acquired resistance

Medicine and Health

Combined KRAS G12C and SOS1 inhibition enhances and extends the anti-tumor response in KRAS G12C -driven cancers by addressing intrinsic and acquired resistance

V. Thatikonda, H. Lu, et al.

This research conducted by Venu Thatikonda and colleagues explores a promising therapeutic strategy in targeting KRAS G12C with the SOS1-KRAS interaction inhibitor, BI-3406. The combination shows a superior anti-tumor response, overcoming resistance mechanisms in lung and colorectal cancer models.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny